Humacyte, Inc. HUMA

Full chart Compare
Set alert

Price alert · HUMA

All alert types
0.44 USD +0.04 (+10.65%)

At closeNov 3, 2026, 7:57 PM EST

0.45 +0.01 +2.16%

After hours · Nov 3, 7:57 PM ET

0.391 Day range 0.4452
0.337 52-week range 1.56
YTD
-54.16%
1 year
-72.30%

Revenue & Expenses

Other Income → Expenses: $66.60MExpenses → Gross Loss: $15.01MExpenses → Selling, General & Admin: $31.17MExpenses → Research & Development: $69.30MOther Operating Income → Expenses: $8.04MNet Loss → Expenses: $40.83MRevenue → Cost of Revenue: $2.04MOther Income$66.60MOther Operating Income$8.04MNet Loss$40.83MCost of Revenue$17.05MExpenses$115.48MGross Loss$15.01MSelling, General & Admin$31.17MResearch & Development$69.30MRevenue$2.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

HUMA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.04M001.56M1.26M
-7.66M001.56M1.26M
-108.14M-114.40M-100.05M-84.58M-81.21M
-40.83M-148.70M-110.78M-11.96M-26.48M
-0.26-1.26-1.07-0.12-0.66
HUMA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
50.71M95.15M80.66M149.77M217.50M
116.37M137.87M128.22M204.30M286.53M
113.26M190.54M114.68M87.37M164.36M
64.85M80.78M57.45M50.07M51.18M
3.11M-52.67M13.55M116.93M122.17M
HUMA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-105.04M-98.12M-73.31M-71.13M-81.19M
-884.00K-1.57M-173.00K4.84M-8.22M
61.49M114.18M4.51M-1.45M266.98M
-884.00K-1.57M-2.28M-1.05M-220.00K
-44.44M14.49M-68.97M-67.73M177.57M